Aclaris Therapeutics, Inc., announced the FDA approved ESKATAâ„¢ (hydrogen peroxide) topical solution, 40% (w/w) for the treatment of seborrheic keratoses
This content is restricted to site members. If you are an existing user, please log in. New users may register below.
